Neurological

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC20-21

DiraChart Clinical Reference
Protected section 21 of 26
← Document menu
Home Care · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 21 of 26PreviousNext

16. Weak vs. strong documentation

The recurring failures (left), why each fails (center), and the corrected, defensible pattern (right). Weak and strong examples are combined here so reviewers see the transformation directly.

Weak — does not survive

Why it fails

Strong — defensible

“Neuro intact.”

No examination components, stroke screen, or skilled rationale.

“Alert, mental status at baseline; cranial nerves grossly intact; motor 5/5 symmetric, no drift; coordination intact; gait steady; stroke screen negative; no focal deficits. RN judgment applied to screen for stroke and detect acute change given the diagnosis.”

“Weakness.”

No group, grade, symmetry, onset, or stroke screen.

“New right-arm weakness graded 3/5 versus 5/5 on the left, of sudden onset, with a facial droop and slurred speech — a positive stroke screen; 911 activated and last-known-well time recorded.”

“A&O, moving all extremities.”

No cranial nerves, symmetry, drift, or gait.

“Alert and oriented; face symmetric and speech clear; strength 5/5 and symmetric with no pronator drift; gait steady with a walker; no focal deficit.”

“Had a seizure.”

No description, duration, or response.

“Witnessed generalized seizure lasting about 90 seconds with a post-ictal period; seizure-safety measures applied and the patient protected; provider notified and antiepileptic adherence reviewed.”

“Taught stroke signs.”

No specific content, method, or measured mastery.

“Reviewed F.A.S.T. stroke warning signs and the imperative to call 911 immediately using teach-back; the caregiver restated the signs and the action; teach-back 100%.”

“Dizzy.”

Not characterized or screened for stroke.

“New dizziness with imbalance and a subtle gait change; BE-FAST screened and balance/eye findings assessed; provider notified and evaluation coordinated.”

Section NavigationPart 21 of 26PreviousNext